114 related articles for article (PubMed ID: 38578391)
1. Predictive value of free triiodothyronine to free thyroxine ratio on contrast-associated acute kidney injury and poor prognosis in euthyroid patients after percutaneous coronary intervention.
Zeng JL; Zhang LW; Liang WJ; You Z; Chen JH; Chen LC; Lin KY; Guo Y
Int Urol Nephrol; 2024 Apr; ():. PubMed ID: 38578391
[TBL] [Abstract][Full Text] [Related]
2. Free triiodothyronine to free thyroxine ratio as a marker of poor prognosis in euthyroid patients with acute coronary syndrome and diabetes after percutaneous coronary intervention.
Wang S; Wang Y; Sun S; Li F; Zhao W; Li X; Ye M; Niu Y; Wu X
Front Endocrinol (Lausanne); 2024; 15():1322969. PubMed ID: 38654927
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study.
Yuan D; Jia S; Zhu P; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
Front Endocrinol (Lausanne); 2021; 12():700349. PubMed ID: 34290672
[TBL] [Abstract][Full Text] [Related]
4. Predictive Value of Free Triiodothyronine to Free Thyroxine Ratio in Euthyroid Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.
Gao S; Ma W; Huang S; Lin X; Yu M
Front Endocrinol (Lausanne); 2021; 12():708216. PubMed ID: 34394005
[TBL] [Abstract][Full Text] [Related]
5. Value of the fT3/fT4 ratio and its combination with the GRACE risk score in predicting the prognosis in euthyroid patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study.
Yu T; Tian C; Song J; He D; Wu J; Wen Z; Sun Z; Sun Z
BMC Cardiovasc Disord; 2018 Sep; 18(1):181. PubMed ID: 30200880
[TBL] [Abstract][Full Text] [Related]
6. Low free triiodothyronine is associated with contrast-induced acute kidney injury and long-term outcome in elderly patients who underwent percutaneous coronary intervention.
Lin C; Lin K; Guo Y; You Z; Zheng W; Lin F; Guo T; Zhu P
Anatol J Cardiol; 2019 Feb; 21(2):60-67. PubMed ID: 30694798
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of free triiodothyronine (FT3) to free thyroxine (FT4) ratio in long-term outcomes of euthyroid patients with three-vessel coronary artery disease.
Yuan D; Zhang C; Jia S; Liu Y; Jiang L; Xu L; Zhang Y; Xu J; Xu B; Hui R; Gao R; Gao Z; Song L; Yuan J
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):579-586. PubMed ID: 33250369
[TBL] [Abstract][Full Text] [Related]
8. High free triiodothyronine and free-triiodothyronine-to-free-thyroxine ratio levels are associated with metabolic syndrome in a euthyroid population.
Urrunaga-Pastor D; Guarnizo-Poma M; Moncada-Mapelli E; Aguirre LG; Lazaro-Alcantara H; Paico-Palacios S; Pantoja-Torres B; Benites-Zapata VA;
Diabetes Metab Syndr; 2018; 12(2):155-161. PubMed ID: 29254889
[TBL] [Abstract][Full Text] [Related]
9. FT3/FT4 Enhances Risk Assessment in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Based on GRACE 2.0 Score.
Han C; Wang L; Liu C; Qi W; Zhang R; Wei A; Yang H; Wang C; Hu Y; Xu J; Zhang Y; Li W; Li T; Jin D; Cong H; Zhang J
Angiology; 2023 Oct; ():33197231199228. PubMed ID: 37876209
[TBL] [Abstract][Full Text] [Related]
10. The serum free triiodothyronine to free thyroxine ratio as a potential prognostic biomarker of chronic kidney disease in patients with glomerular crescents: A retrospective study.
Zhang L; Wu Y; Nie Y; Lv W; Li Y; Zhu B; Jin S; Shen Z; Li F; Liu H; Fang Y; Ding X
Front Endocrinol (Lausanne); 2022; 13():977355. PubMed ID: 36246924
[TBL] [Abstract][Full Text] [Related]
11. Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population.
Liu HX; Ren YY; Meng CQ; Li Z; Nie Q; Yu CH; Ma HJ
Front Endocrinol (Lausanne); 2022; 13():961803. PubMed ID: 36105392
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Systemic Inflammation Score for Contrast-Associated Acute Kidney Injury and Adverse Outcomes Among Patients Undergoing Elective Percutaneous Coronary Intervention.
Zeng JL; Xiang YF; Zhang LW; Chen LC; Chen JH; Liang WJ; You Z; Wang CX; Lin ZJ; Lin KY; Guo Y
J Inflamm Res; 2023; 16():2845-2854. PubMed ID: 37449284
[TBL] [Abstract][Full Text] [Related]
13. Negative association between free triiodothyronine level and contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention.
Lin KY; Wang SY; Jiang H; Chen HC; Wu ZY; Guo YS; Zhu PL
BMC Nephrol; 2019 Jun; 20(1):201. PubMed ID: 31159763
[TBL] [Abstract][Full Text] [Related]
14. Interaction between triglyceride-glucose index and thyroid hormones on coronary artery disease risk in patient with euthyroid.
Li L; Cai G; Lu W; Li F; Yu L; Xiao J
Front Endocrinol (Lausanne); 2023; 14():1255656. PubMed ID: 38179310
[TBL] [Abstract][Full Text] [Related]
15. The Association of Thyroid Hormones With Cardiogenic Shock and Prognosis in Patients with ST Segment Elevation Myocardial Infarction (STEMI) Treated with Primary PCI.
Xue Y; Zhu Y; Shen J; Zhou W; Xiang J; Xiang Z; Wang L; Luo S
Am J Med Sci; 2022 Mar; 363(3):251-258. PubMed ID: 34547284
[TBL] [Abstract][Full Text] [Related]
16. Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus.
He X; Gao R; Wu Y; Wu K; Sun J; Zhang X; Liu L; Chen L
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362757
[TBL] [Abstract][Full Text] [Related]
17. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of aspartate aminotransferase-to-alanine aminotransferase ratio for contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention.
He HM; He C; Zhang SC; You ZB; Lin XQ; Luo MQ; Lin MQ; Guo YS; Zheng WP; Lin KY
J Cardiol; 2022 May; 79(5):618-625. PubMed ID: 34857433
[TBL] [Abstract][Full Text] [Related]
19. FT4/FT3 ratio: A novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients.
Zhang H; Che W; Shi K; Huang Y; Xu C; Fei M; Fan X; Zhang J; Hu X; Hu F; Qin S; Zhang X; Huang Q; Yu F
Front Endocrinol (Lausanne); 2022; 13():1021326. PubMed ID: 36187090
[TBL] [Abstract][Full Text] [Related]
20. [The prognostic value of free triiodothyronine/free thyroxine ratio in patients hospitalized with heart failure].
Zhou P; Huang LY; Zhai M; Huang Y; Zhuang XF; Liu HH; Zhang YH; Zhang J
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1679-1684. PubMed ID: 37302858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
